All News

Compassionate and Professional Oncology Nurses Make All the Difference For Patients with Cancer

November 29th 2020, 3:00pm

Article

Patients with cancer discuss how compassionate and professional oncology nurses make all the difference on their care teams as they go through the cancer journey.

By My Side As an Oncology Nurse — And a Friend

November 28th 2020, 3:00pm

Article

A cancer survivor describes how her oncology nurse was by her side through her cancer journey as both a nurse, and her friend.

Oncology Nurses Are Compassionate, Empathetic and Knowledgeable

November 27th 2020, 10:00pm

Article

An oncology nurse recounts how her fellow nurses are compassionate, empathetic and knowledgeable towards patients with cancer.

Fertility Preservation Boosts Birth Rate After Breast Cancer Treatment

November 27th 2020, 7:00pm

Article

Women with breast cancer who undergo fertility preservation with breast cancer are more likely to give birth than those who do not, researchers report.

Friday Frontline: NCI Research Project Identifies Genomic Mutations That Helped “Exceptional Responders”, a 15-Year-Old Cancer Survivor Dies of COVID-19, And More

November 27th 2020, 4:00pm

Article

Form the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

CURE’s Clinical Trial Corner: November 2020

November 26th 2020, 2:00pm

Article

Here is a list of some recent trials that launched within the cancer space in November.

FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma

November 25th 2020, 11:13pm

Article

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

First-Line Treatment with Additional Combination Therapy After Resection May Improve Survival for Pancreatic Cancer

November 25th 2020, 10:00pm

Article

This survival benefit was particularly observed in patients with node-positive disease, or cancer that spread to the lymph nodes according to pathology.

Keytruda With an Androgen Receptor Modulator May Produce a Modest Benefit in Women with Androgen Receptor-Positive, Triple-Negative Breast Cancer

November 25th 2020, 4:00pm

Article

Despite a modest benefit in these patients, principal investigator Dr. Yuan Yuan said she is looking “forward to the future” with regards to therapies that integrate nonsteroidal selective androgen receptor modulators for this patient population.

Navigating Both Cancer and a Viral Pandemic Is a Difficult Balancing Act

November 25th 2020, 2:00pm

Article

Living with cancer is not dissimilar to the challenges the COVID-19 pandemic is presenting all of us, but living with cancer during this pandemic is a challenge all to itself, a tough balancing out to pull off.

x